AC, D., W, B., C, L., GM, G., A, B., H, E., . . . RS, O. (2022). Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting Approach. Drug metabolism and disposition: the biological fate of chemicals, 50(9), . https://doi.org/10.1124/dmd.122.000884
Chicago Style (17th ed.) CitationAC, Doran, Burchett W, Landers C, Gualtieri GM, Balesano A, Eng H, Dantonio AL, Goosen TC, and Obach RS. "Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting Approach." Drug Metabolism and Disposition: The Biological Fate of Chemicals 50, no. 9 (2022). https://doi.org/10.1124/dmd.122.000884.
MLA (9th ed.) CitationAC, Doran, et al. "Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting Approach." Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 50, no. 9, 2022, https://doi.org/10.1124/dmd.122.000884.